Investors Heavily Search Williams-Sonoma, Inc. Here is What You Need to Know
| SNOA Stock | USD 2.85 0.06 2.06% |
About 62% of Sonoma Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Sonoma Pharmaceuticals stock suggests that many investors are alarmed at this time. The current market sentiment, together with Sonoma Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Sonoma Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Sonoma |
Williams-Sonoma has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stocks prospects.
Read at finance.yahoo.com
 |
Sonoma Pharmaceuticals Fundamental Analysis
We analyze Sonoma Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sonoma Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sonoma Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
Sonoma Pharmaceuticals is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Sonoma Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sonoma Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Sonoma Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Sonoma Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Sonoma Pharmaceuticals Related Equities
| SBFM | Sunshine Biopharma | 11.32 | ||||
| UPC | Universe Pharmaceuticals | 7.82 | ||||
| LFCR | Lifecore Biomedical | 4.73 | ||||
| PTPI | Petros Pharmaceuticals | 3.85 | ||||
| DERM | Journey Medical | 3.27 | ||||
| AKAN | Akanda Corp | 1.49 | ||||
| SGIOY | Shionogi | 0.76 | ||||
| TKNO | Alpha Teknova | 0.69 | ||||
| SHPH | Shuttle Pharmaceuticals | 1.14 | ||||
| SXTC | China SXT | 2.56 | ||||
| LOVFF | Cannara Biotech | 4.44 | ||||
| CPHI | China Pharma | 5.00 |
Complementary Tools for Sonoma Stock analysis
When running Sonoma Pharmaceuticals' price analysis, check to measure Sonoma Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sonoma Pharmaceuticals is operating at the current time. Most of Sonoma Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Sonoma Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sonoma Pharmaceuticals' price. Additionally, you may evaluate how the addition of Sonoma Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |